The SWITCH1 trial: Proving that Lantus/Basaglar has a higher Hypocglycaemia rate than Tresiba
Let’s start with the SWITCH 1 trial. What is it? It was a Phase 3a trial to compare the hypoglycaemia benefit of the two insulins. […]
Let’s start with the SWITCH 1 trial. What is it? It was a Phase 3a trial to compare the hypoglycaemia benefit of the two insulins. […]
The EASD Virtual Meeting place has been a revelation. It’s allowed me to view the sessions that I wanted the DOC that’s present at the […]
Gutted as I and many others of the GBDOC are to not be at the European Association for the Study of Diabetes (EASD) annual meeting […]
Following yesterday’s NNF conference on Continuous Glucose Monitoring (CGM) and the ensuing Twitter debate that frequently happens with these types of event, I gave some […]
Two weeks off work in Cornwall. A great time to sit in the sun and build an Artificial Pancreas. What an amazing world we live […]
Last night at the JDRF Discovery Evening in the City, a company named Medtrum sponsored the event. A company many of us have never heard […]
I’ve had the 640G for a while now, running SmartGuard, and I really like the technology, as I’ve mentioned in a few blog posts (if […]
Having now used the 640G for three months, I felt that I now have a good handle on it, how it works and how it […]
As many people will be aware, the All Parties Parliamentary Group for Diabetes has asked for written evidence submissions from diabetics of all ages and […]
As I mentioned on Twitter not so long ago, I’ve been undertaking a low carb diet for a few weeks as a great way to […]
Copyright © 2025 | WordPress Theme by MH Themes